Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
暂无分享，去创建一个
A. Doney | C. Hawkey | A. Avery | J. Dawson | J. Townend | A. Struthers | C. Kerr | L. Ritchie | M. Eddleston | E. Rooke | A. Fuat | MorrisJ. Brown | N. Greenlaw | A. Begg | M. Denvir | I. Mackenzie | H. Routledge | K. Zutis | D. Preiss | M. Dryburgh | S. Doshi | D. Sims | A. Mackintosh | M. Randall | F. Pigazzani | C. Jennings | Robbie Guerriero Wilson | C. Petrie | T. McCormack | Li Wei | J. Trevelyan | S. Duce | T. M. Macdonald | Jaspal S Taggar | K. Krishnan | J. Furnace | A. Rogers | R. Weir | I. Ford | J. Taggar | K. Wetherall | J. Finlayson | J. Dumbleton | M. MacLeod | G. Guthrie | Richard Johnson | David Newby | C. Weir | Rebecca Barr | A. Nadir | Sarah Boyle | Adam Wilson | S. Khan | P. McEleny | Monique Morar | Andrew Walker | Bridget Shepherd | Susan Long | Peter Arthur | Husnat Ahmed | Jane Aziz | Lawrence Barnes | Tom Brighton | M. Caulfield | Jwm Grieve | Sharon Ham | Emma Isaard | Stuart Ralston | S. Shakir | R. Sharma | Gordon Snedden | R. Barr | G. Snedden | Rebecca J Barr